Middle East & Africa Acute Pancreatitis Market
Acute pancreatitis is an inflammatory disorder of the pancreas. The condition is associated with increased morbidity and mortality because there is no specific treatment approved to treat it, leaving supportive care as the main course of treatment. A targeted novel treatment strategy that halts disease progression and improves patient outcomes is needed to address the current disease burden of acute and severe acute pancreatitis. An article published in the National Library of Medicine in February 2023 focuses on 3 major approaches to advance acute pancreatitis treatments—the clinical identification and application of new genetic information; newly identified serum biomarkers, i.e., fatty acid ethyl esters (FAEEs); and acceleration in timing of early nutrition feedings in acute pancreatitis.
Clinical Identification and Application of New Genetic Information: When acute pancreatitis occurs at the age of 35 years or when it is relapsing or idiopathic, testing for the 6 commercially evaluable genetic causes of acute pancreatitis is recommended. This test provides valuable information regarding the diagnosis probability of genetic predisposition, cofactors that are likely to play a role in disease identification and a suitable approach to initiate treatment early in the process, without requiring repeated testing. Newly Identified Serum Biomarkers—FAEEs: During a prospective, blinded trial, researchers compared the levels of FAEE, nonesterified fatty acids, and ethanol in the blood of 175 patients hospitalized for alcoholic pancreatitis, alcohol intoxication, nonalcoholic pancreatitis, and normal controls. This test has the unique capability of demonstrating diagnostic elevations of FAEEs associated with alcohol consumption. Therefore, it can be evaluated that alcohol is the cause of alcohol-associated pancreatitis and to exclude it when there are other causes. Important Acceleration in Timing of Early Feedings in Acute Pancreatitis: The practice of beginning early feeding through the nasogastric/nasojejunal routes after the onset of acute pancreatitis has been supported by multiple randomized controlled trials and has replaced the practice of resting the gastrointestinal tract until pain subsides prior to feeding. This approach results in increased bowel motility and reduced organ failure, infection, length of stay, and mortality rates, confirming that an idle intestine leads to bacterial overgrowth, increased permeability, and bacterial translocation.
Such developments in specific treatment approaches would lead to new treatment options to enhance outcomes and improve the acute pancreatitis market in the near future.
The Middle East & Africa acute pancreatitis market is segmented into UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The growing geriatric population, growing healthcare infrastructure, and adoption of advanced technologies in healthcare are the factors that support the growth of the market in the region.
Saudi Arabia is one of the fastest-growing countries in the Middle East & Africa. Changing healthcare infrastructure and public–private partnerships between government and international players are strengthening the healthcare sector in the country. These partnerships and privatization efforts are in line with the policies included in the “Vision 2030” strategy by the Saudi government for the transformation national economy. As per the “Rights and Wellbeing of Older Persons in Saudi Arabia” report, the number of people aged 60 or more is predicted to increase five-fold during 2020–2050, rising from 2 million (5.9% of the total population) to 10.5 million (23.7% of the population). Also, the number of people aged 80 or more is expected to reach 1.6 million, i.e., 4% of the total population by 2050. As per a study titled “Epidemiological Features of Acute Pancreatitis,” published in 2023, gallstones and alcohol consumption are the leading causes of acute pancreatitis, together accounting for 60% of the total cases in Saudi Arabia. Acute pancreatitis incidence among patients suffering from abdominal pain was 11.6% during 2017–2021. Concerning the incidence rate of the condition between genders, many Saudi researchers over the last 3 decades have agreed that acute pancreatitis is more prevalent in males than in females.
The Middle East & Africa acute pancreatitis market is segmented offerings, causes, end user
Based on offerings, the Middle East & Africa acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.
Based on causes, the Middle East & Africa acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.
Based on end user, the Middle East & Africa acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Middle East & Africa acute pancreatitis market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa acute pancreatitis market in 2022.
Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Middle East & Africa acute pancreatitis market.
Strategic insights for the Middle East & Africa Acute Pancreatitis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 131.64 Million |
| Market Size by 2030 | US$ 156.24 Million |
| Global CAGR (2022 - 2030) | 2.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Offerings
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
The geographic scope of the Middle East & Africa Acute Pancreatitis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Middle East & Africa Acute Pancreatitis Market is valued at US$ 131.64 Million in 2022, it is projected to reach US$ 156.24 Million by 2030.
As per our report Middle East & Africa Acute Pancreatitis Market, the market size is valued at US$ 131.64 Million in 2022, projecting it to reach US$ 156.24 Million by 2030. This translates to a CAGR of approximately 2.2% during the forecast period.
The Middle East & Africa Acute Pancreatitis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Acute Pancreatitis Market report:
The Middle East & Africa Acute Pancreatitis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Acute Pancreatitis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Acute Pancreatitis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Acute Pancreatitis Market
